SCHEMBL3119031

SCHEMBL3119031

CCCCCn1c(=O)n(CCCCc2ccc(-c3ccccc3)cc2)c(=O)c2[nH]c(Cl)nc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 9/20 0.54
ADORA2A P29274 8/20 0.54
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 2/20 0.54
CYP1A2 P05177 2/20 0.54
CYP3A4 P08684 2/20 0.54
HSD17B10 Q99714 2/20 0.54
MEN1 O00255 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
KMT2A Q03164 1/20 0.54
ADORA1 P30542 7/20 0.52
SIRT1 Q96EB6 1/20 0.48
SIRT3 Q9NTG7 1/20 0.48
SIRT5 Q9NXA8 1/20 0.48
ADORA3 P0DMS8 3/20 0.48
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
THPO P40225 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL843582 0.98 ADORA2B (0.54) ADORA2BADORA2AKDM4EALDH1A1CYP1A2
SCHEMBL3115718 0.94 ADORA2A (0.55) ADORA2BADORA2AKDM4EALDH1A1CYP1A2
SCHEMBL3120997 0.91 ADORA2A (0.52) ADORA2BADORA2AKDM4EALDH1A1CYP1A2
SCHEMBL3119974 0.89 ADORA2A (0.52) ADORA2BADORA2AKDM4EALDH1A1CYP1A2
SCHEMBL3106241 0.88 ADORA2B (0.58) ADORA2BADORA2AKDM4EALDH1A1CYP1A2
SCHEMBL3105367 0.88 ADORA2B (0.54) ADORA2BADORA2AADORA1
SCHEMBL3105247 0.88 ADORA1 (0.51) ADORA2BADORA2AADORA1
SCHEMBL3116990 0.87 ADORA2B (0.49) ADORA2BADORA2AADORA1SIRT1SIRT3
SCHEMBL3620246 0.86 SIRT1 (0.61) ADORA2BADORA2AKDM4EALDH1A1CYP1A2
SCHEMBL3115736 0.86 SIRT1 (0.57) ADORA2BADORA2AADORA1SIRT1SIRT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 ADORA2B 111/4885ADORA2A 17/4885KDM4E 4566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.